Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion type Assertion NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_head.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion wasGeneratedBy ECO_0000203 NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_provenance.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion wasDerivedFrom befree-2016 NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_provenance.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion SIO_000772 16381942 NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_provenance.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion evidence source_evidence_literature NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_provenance.
- NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_assertion description "[Tumor-associated antigens (TAAs) have been the most actively employed targets in the clinical diagnosis and treatment of human carcinoma, such as PSA in the diagnosis of prostate cancer and NY-ESO-1 in the immunotherapy of melanoma and other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528729.RACURUWbA--rxhIBJlCvO5uWBqaF_vxelBqPju6LNvdKM130_provenance.